Duker Jay S. (CIK 0001630864)

Latest company ownership

Shares held
22,500
Last filed at
Feb 28, 2024
Confidence Score
46.7
2025Q4
Confidence Score History
2019Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 10, 2025 Jul 11, 2025 EyePoint Pharmaceuticals, Inc. CEO Sell 42.5 -7,688 -6.58% ✗ $85K
Jun 23, 2025 Jun 25, 2025 EyePoint Pharmaceuticals, Inc. CEO Sell 20.0 -56,665 -36.13% ✗ $465.2K
Mar 19, 2025 Mar 20, 2025 EyePoint Pharmaceuticals, Inc. CEO Sell 22.5 -20,000 -16.65% ✗ $123.1K
Feb 9, 2025 Feb 11, 2025 EyePoint Pharmaceuticals, Inc. CEO Sell 46.3 -2,055 -2.01% ✗ $13.3K
Jan 5, 2025 Jan 7, 2025 EyePoint Pharmaceuticals, Inc. CEO Sell 42.5 -16,115 -9.52% ✗ $135.7K
Jul 10, 2024 Jul 12, 2024 EyePoint Pharmaceuticals, Inc. CEO Sell 42.5 -8,059 -11.75% ✗ $70K
Feb 9, 2024 Feb 13, 2024 EyePoint Pharmaceuticals, Inc. CEO Sell 42.5 -3,533 -6.37% ✗ $101.8K
Jan 6, 2024 Jan 9, 2024 EyePoint Pharmaceuticals, Inc. CEO Sell 42.5 -6,528 -13.05% ✗ $133.2K
Feb 9, 2023 Feb 13, 2023 EyePoint Pharmaceuticals, Inc. COO Sell 46.3 -4,148 -12.43% ✗ $17.3K
Nov 1, 2022 Nov 3, 2022 EyePoint Pharmaceuticals, Inc. COO Sell 46.3 -4,479 -17.31% ✗ $24.3K
Apr 1, 2019 Apr 3, 2019 EyePoint Pharmaceuticals, Inc. Director Buy 90.0 +5,000 40.00% ✗ $9.5K